OVID · NASDAQ · Pharmaceutical Preparations
No fund moves found
Nothing has been reported for this company in this source yet.
Institutions reporting a stake, Q2 2026
130
+27 vs Q1 2026
Share of stock reported
75.3%
147M of 195M shares outstanding
Change vs Q1 2026
+31.9M shares
45 new positions, 18 positions closed
Reported in 13F filings, which cover managers over $100M and include double counting. A 13F shows holdings on the last day of the quarter, not when shares were bought or sold. Change counts the 129 managers that reported both quarters.
Source: SEC Form 13F data sets, every filer, common stock only (options and bonds left out); 2 managers also reported puts and 2 managers calls. Amendments are applied; lines whose value was filed in thousands are scaled, and lines whose shares and value disagree are left out.